Thrombospondin-1 is an endogenous activator of TGF-β in experimental diabetic nephropathy in vivo

Diabetes

Volumn 56, Issue 12, 2007, Pages 2982-2989

  Daniel, Christoph ^a   Schaub, Kathrin ^a   Amann, Kerstin ^a   Lawler, Jack ^b   Hugo, Christian ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GENE PRODUCT; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMAD2 PROTEIN; SMAD3 PROTEIN; STREPTOZOCIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; IMMUNOHISTOLOGY; IN VIVO STUDY; INFLAMMATORY INFILTRATE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION TEST; KIDNEY INJURY; MOUSE; NONHUMAN; PLASMINOGEN ACTIVATION; PODOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SPECIES COMPARISON; STREPTOZOCIN DIABETES; TISSUE SECTION; WILD TYPE;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; KIDNEY; MICE; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

EID: 36849066969     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db07-0551     Document Type: Article

References (43)

1. World Health Organization: Diabetes: World Health Organization Fact Sheet. Geneva, World Health Organization, 2006, p. 1-2 (no. 312)
2. Russell TA: Diabetic nephropathy in patients with type 1 diabetes mellitus. Nephrol Nurs J 33:15-28; quiz 29-30, 2006
3. Nicholas SB: Advances in pathogenetic mechanisms of diabetic nephropathy. Cell Mol Biol (Noisy-le-grand) 49:1319-1325, 2003
4. Broumand B: Diabetes: changing the fate of diabetics in the dialysis unit. Blood Purif 25:39-47, 2007
5. Pantsulaia T: Role of TGF-beta in pathogenesis of diabetic nephropathy. Georgian Med News 131:13-18, 2006
6. Ziyadeh FN: Mediators of diabetic renal disease: the case for tgf-beta as the major mediator. J Am Soc Nephrol 15 (Suppl. 1):S55-S57, 2004
7. Lawrence DA: Transforming growth factor-beta: a general review. Eur Cytokine Netw 7:363-374, 1996
8. Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE: The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 274:13586-13593, 1999
9. Schultz-Cherry S, Chen H, Mosher DF, Misenheimer TM, Krutzsch HC, Roberts DD, Murphy-Ullrich JE: Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem 270:7304-7310, 1995
10. Yevdokimova N, Wahab NA, Mason RM: Thrombospondin-1 is the key activator of TGF-beta1 in human mesangial cells exposed to high glucose. J Am Soc Nephrol 12:703-712, 2001
11. Poczatek MH, Hugo C, Darley-Usmar V, Murphy-Ullrich JE: Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1. Am J Pathol 157:1353-1363, 2000
12. Yung S, Lee CY, Zhang Q, Lau SK, Tsang RC, Chan TM: Elevated glucose induction of thrombospondin-1 up-regulates fibronectin synthesis in proximal renal tubular epithelial cells through TGF-beta1 dependent and TGF-beta1 independent pathways. Nephrol Dial Transplant 21:1504-1513, 2006
13. Yang YL, Chuang LY, Guh JY, Liu SF, Hung MY, Liao TN, Huang YL: Thrombospondin-1 mediates distal tubule hypertrophy induced by glycated albumin. Biochem J 379:89-97, 2004
14. Wang S, Wu X, Lincoln TM, Murphy-Ullrich JE: Expression of constitutively active cGMP-dependent protein kinase prevents glucose stimulation of thrombospondin 1 expression and TGF-β activity. Diabetes 52:2144-2150, 2003
15. Wang S, Skorczewski J, Feng X, Mei L, Murphy-Ullrich JE: Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-beta activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2. J Biol Chem 279:34311-34322, 2004
16. Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, Schaefer R, Mason RM: Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabetologia 48:2650-2660, 2005
17. Daniel C, Takabatake Y, Mizui M, Isaka Y, Kawashi H, Rupprecht H, Imai E, Hugo C: Antisense oligonucleotides against thrombospondin-1 inhibit activation of tgf-beta in fibrotic renal disease in the rat in vivo. Am J Pathol 163:1185-1192, 2003
18. Daniel C, Wiede J, Krutzsch HC, Ribeiro SM, Roberts DD, Murphy-Ullrich JE, Hugo C: Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo. Kidney Int 65:459-468, 2004
19. Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO: Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 101:982-992, 1998
20. Sharma K, Wang L, Zhu Y, DeGuzman A, Cao GY, Lynn RB, Joseph SK: Renal type I inositol 1,4,5-trisphosphate receptor is reduced in streptozotocin- induced diabetic rats and mice. Am J Physiol 276:F54-F61, 1999
21. Taneda S, Pippin JW, Sage EH, Hudkins KL, Takeuchi Y, Couser WG, Alpers CE: Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol 14:968-980, 2003
22. Tesch GH, Allen TJ: Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton) 12:261-266, 2007
23. Hugo C, Shankland SJ, Pichler RH, Couser WG, Johnson RJ: Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat. Kidney Int 53:302-311, 1998
24. Hohenstein B, Kasperek L, Kobelt DJ, Daniel C, Gambaryan S, Renne T, Walter U, Amann KU, Hugo CP: Vasodilator-stimulated phosphoprote-indeficient mice demonstrate increased platelet activation but improved renal endothelial preservation and regeneration in passive nephrotoxic nephritis. J Am Soc Nephrol 16:986-996, 2005
25. Hugo C, Pichler R, Meek R, Gordon K, Kyriakides T, Floege J, Bornstein P, Couser WG, Johnson RJ: Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. Kidney Int 48:1846-1856, 1995
26. Riley SG, Steadman R, Williams JD, Floege J, Phillips AO: Augmentation of kidney injury by basic fibroblast growth factor or platelet-derived growth factor does not induce progressive diabetic nephropathy in the Goto Kakizaki model of non-insulin-dependent diabetes. J Lab Clin Med 134:304-312, 1999
27. Hughes J, Johnson RJ, Mooney A, Hugo C, Gordon K, Savill J: Neutrophil fate in experimental glomerular capillary injury in the rat: emigration exceeds in situ clearance by apoptosis. Am J Pathol 150:223-234, 1997
28. Daniel C, Amann K, Hohenstein B, Bornstein P, Hugo C: Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in experimental glomerulonephritis in mice. J Am Soc Nephrol 18:788-798, 2007
29. Hartner A, Schaefer L, Porst M, Cordasic N, Gabriel A, Klanke B, Reinhardt DP, Hilgers KF: Role of fibrillin-1 in hypertensive and diabetic glomerular disease. Am J Physiol Renal Physiol 290:F1329-F1336, 2006
30. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, Mathieu C: The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14:33-43, 2003
31. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530, 1996
32. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci U S A 97:8015-8020, 2000
33. Chow FY, Nikolic-Paterson DJ, Ma FY, Ozols E, Rollins BJ, Tesch GH: Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia 50:471-480, 2007
34. Galkina E, Ley K: Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol 17:368-377, 2006
35. Mensah-Brown EP, Obineche EN, Galadari S, Chandranath E, Shahin A, Ahmed I, Patel SM, Adem A: Streptozotocin-induced diabetic nephropathy in rats: the role of inflammatory cytokines. Cytokine 31:180-190, 2005
36. Kitamura M, Fine LG: Evidence for TGF-beta-mediated 'defense' of the glomerulus: a blackguard molecule rehabilitated? Exp Nephrol 6:1-6, 1998
37. Kitamura M: Adoptive transfer of genetically modified macrophages elucidated TGF-beta-mediated 'self-defence' of the glomerulus against local action of macrophages. Nephrol Dial Transplant 14 (Suppl. 1):35-38, 1999
38. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359:693-699, 1992
39. Wang W, Koka V, Lan HY: Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) 10:48-56, 2005
40. Wang SN, LaPage J, Hirschberg R: Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int 57:1002-1014, 2000
41. Vallejo AN, Mugge LO, Klimiuk PA, Weyand CM, Goronzy JJ: Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells. J Immunol 164:2947-2954, 2000
42. Breyer MD, Bottinger E, Brosius FC III, Coffman TM, Harris RC, Heilig CW, Sharma K: Mouse models of diabetic nephropathy. J Am Soc Nephrol 16:27-45, 2005
43. Moczulski DK, Fojcik H, Wielgorecki A, Trautsolt W, Gawlik B, Kosiorz-Gorczynska S, Oczko-Wojciechowska M, Wiench M, Strojek K, Zukowska-Szczechowska E, Grzeszczak W: Expression pattern of genes in peripheral blood mononuclear cells in diabetic nephropathy. Diabet Med 24:266-271, 2007